Sorafenib, Valproic Acid, and Sildenafil in Treating Patients With Recurrent High-Grade Glioma
Clinical trial NCT01817751 · COMPLETED
Trial details
- NCT number
- NCT01817751
- Sponsor
- Virginia Commonwealth University
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-04-11
- Primary completion
- 2020-08-27
- Enrollment
- 47
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.